MeVi Limited – Trademark Portfolio
Entity Type: 99
MeVi Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GIAPO.
CodeBase,
Argyle House,; 3 Lady Lawson Street; Edinburgh EH3 9DR
Showing of trademarks Trademarks
Trademark Classifications
MeVi Limited's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does MeVi Limited have?
MeVi Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does MeVi Limited file in?
MeVi Limited files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants), Class 30 (Staple Foods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MeVi Limited's most well-known trademarks?
MeVi Limited's registered trademark portfolio includes well-known marks such as GIAPO. These are among 1 currently registered trademark in the portfolio.
What is MeVi Limited's trademark registration success rate?
MeVi Limited has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.